PRF1 and metabolic dysfunction-associated steatotic liver disease: Given that TRAIL-mediated cytotoxicity exacerbates NAFLD (24, 25), we speculated that there might be some advantage to the reduced perforin-mediated cytotoxicity we observed in the obese liver.